List of Ambit Biosciences patents

Patents where

Current Assignee

Name

Ambit Biosciences

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 9555040 Methods of treating proliferative diseases	Patent 9555040 was granted and assigned to Ambit Biosciences on January, 2017 by the United States Patent and Trademark Office.	Ambit Biosciences	Ambit Biosciences	United States Patent and Trademark Office	9555040	January 31, 2017
‌ US Patent 7112435 Uncoupling of DNA insert propagation and expression of protein for phage display	Patent 7112435 was granted and assigned to Ambit Biosciences on September, 2006 by the United States Patent and Trademark Office.		Ambit Biosciences	United States Patent and Trademark Office	7112435	September 26, 2006
‌ US Patent 7323490 Pyrrole compounds and uses thereof	Patent 7323490 was granted and assigned to Ambit Biosciences on January, 2008 by the United States Patent and Trademark Office.		Ambit Biosciences	United States Patent and Trademark Office	7323490	January 29, 2008
‌ US Patent 7750160 Isoxazolyl urea derivatives as kinase modulators	Patent 7750160 was granted and assigned to Ambit Biosciences on July, 2010 by the United States Patent and Trademark Office.		Ambit Biosciences	United States Patent and Trademark Office	7750160	July 6, 2010
‌ US Patent 8357690 Methods of treatment using combination therapy	Patent 8357690 was granted and assigned to Ambit Biosciences on January, 2013 by the United States Patent and Trademark Office.		Ambit Biosciences	United States Patent and Trademark Office	8357690	January 22, 2013
‌ US Patent 9320739 RAF kinase modulator compounds and methods of use thereof	Patent 9320739 was granted and assigned to Ambit Biosciences on April, 2016 by the United States Patent and Trademark Office.	Ambit Biosciences	Ambit Biosciences	United States Patent and Trademark Office	9320739	April 26, 2016
‌ US Patent 8969587 RAF kinase modulator compounds and methods of use thereof	Patent 8969587 was granted and assigned to Ambit Biosciences on March, 2015 by the United States Patent and Trademark Office.	Ambit Biosciences	Ambit Biosciences	United States Patent and Trademark Office	8969587	March 3, 2015
‌ US Patent 9730937 RAF kinase modulator compounds and methods of use thereof	Patent 9730937 was granted and assigned to Ambit Biosciences on August, 2017 by the United States Patent and Trademark Office.	Ambit Biosciences	Ambit Biosciences	United States Patent and Trademark Office	9730937	August 15, 2017
‌ US Patent 9585892 Solid forms comprising N-(5-tert-butyl-isoxazol-3-yl)-N′-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea, compositions thereof, and uses therewith	Patent 9585892 was granted and assigned to Ambit Biosciences on March, 2017 by the United States Patent and Trademark Office.	Ambit Biosciences	Ambit Biosciences	United States Patent and Trademark Office	9585892	March 7, 2017
‌ US Patent 7767670 Substituted 3-carboxamido isoxazoles as kinase modulators	Patent 7767670 was granted and assigned to Ambit Biosciences on August, 2010 by the United States Patent and Trademark Office.		Ambit Biosciences	United States Patent and Trademark Office	7767670	August 3, 2010
‌ US Patent 8349851 JAK kinase modulating compounds and methods of use thereof	Patent 8349851 was granted and assigned to Ambit Biosciences on January, 2013 by the United States Patent and Trademark Office.		Ambit Biosciences	United States Patent and Trademark Office	8349851	January 8, 2013
‌ US Patent 9295672 Optically active pyrazolylaminoquinazoline, and pharmaceutical compositions and methods of use thereof	Patent 9295672 was granted and assigned to Ambit Biosciences on March, 2016 by the United States Patent and Trademark Office.	Ambit Biosciences	Ambit Biosciences	United States Patent and Trademark Office	9295672	March 29, 2016
‌ US Patent 8703943 Optically active pyrazolylaminoquinazoline, and pharmaceutical compositions and methods of use thereof	Patent 8703943 was granted and assigned to Ambit Biosciences on April, 2014 by the United States Patent and Trademark Office.		Ambit Biosciences	United States Patent and Trademark Office	8703943	April 22, 2014
‌ US Patent 9296722 Azolyl urea compounds and methods of use thereof	Patent 9296722 was granted and assigned to Ambit Biosciences on March, 2016 by the United States Patent and Trademark Office.		Ambit Biosciences	United States Patent and Trademark Office	9296722	March 29, 2016
‌ US Patent 8952020 Optically active pyrazolylaminoquinazoline, and pharmaceutical compositions and methods of use thereof	Patent 8952020 was granted and assigned to Ambit Biosciences on February, 2015 by the United States Patent and Trademark Office.	Ambit Biosciences	Ambit Biosciences	United States Patent and Trademark Office	8952020	February 10, 2015
‌ US Patent 8927711 JAK kinase modulating compounds and methods of use thereof	Patent 8927711 was granted and assigned to Ambit Biosciences on January, 2015 by the United States Patent and Trademark Office.	Ambit Biosciences	Ambit Biosciences	United States Patent and Trademark Office	8927711	January 6, 2015
‌ US Patent 8633209 Hydrobromide salts of a pyrazolylaminoquinazoline	Patent 8633209 was granted and assigned to Ambit Biosciences on January, 2014 by the United States Patent and Trademark Office.		Ambit Biosciences	United States Patent and Trademark Office	8633209	January 21, 2014
‌ US Patent 9308207 JAK kinase modulating compounds and methods of use thereof	Patent 9308207 was granted and assigned to Ambit Biosciences on April, 2016 by the United States Patent and Trademark Office.	Ambit Biosciences	Ambit Biosciences	United States Patent and Trademark Office	9308207	April 12, 2016
‌ US Patent 8921546 Imidazolothiazole compounds for the treatment of disease	Patent 8921546 was granted and assigned to Ambit Biosciences on December, 2014 by the United States Patent and Trademark Office.	Ambit Biosciences	Ambit Biosciences	United States Patent and Trademark Office	8921546	December 30, 2014
‌ US Patent 8952058 Heterocyclic compounds and methods of use thereof	Patent 8952058 was granted and assigned to Ambit Biosciences on February, 2015 by the United States Patent and Trademark Office.	Ambit Biosciences	Ambit Biosciences	United States Patent and Trademark Office	8952058	February 10, 2015
‌ US Patent 9611253 Solid forms comprising optically active pyrazolylaminoquinazoline, compositions thereof, and uses therewith	Patent 9611253 was granted and assigned to Ambit Biosciences on April, 2017 by the United States Patent and Trademark Office.	Ambit Biosciences	Ambit Biosciences	United States Patent and Trademark Office	9611253	April 4, 2017
‌ US Patent 8836218 Methods of treatment using combination therapy	Patent 8836218 was granted and assigned to Ambit Biosciences on September, 2014 by the United States Patent and Trademark Office.	Ambit Biosciences	Ambit Biosciences	United States Patent and Trademark Office	8836218	September 16, 2014
‌ US Patent 9452167 Heterocyclic compounds and methods of use thereof	Patent 9452167 was granted and assigned to Ambit Biosciences on September, 2016 by the United States Patent and Trademark Office.	Ambit Biosciences	Ambit Biosciences	United States Patent and Trademark Office	9452167	September 27, 2016
‌ US Patent 9675549 Tablet containing composite with cyclodextrin	Patent 9675549 was granted and assigned to Ambit Biosciences on June, 2017 by the United States Patent and Trademark Office.	Ambit Biosciences	Ambit Biosciences	United States Patent and Trademark Office	9675549	June 13, 2017
‌ US Patent 9284332 Process for the preparation of imidazo[2,1-B][1,3]benzothiazole derivatives	Patent 9284332 was granted and assigned to Ambit Biosciences on March, 2016 by the United States Patent and Trademark Office.		Ambit Biosciences	United States Patent and Trademark Office	9284332	March 15, 2016

Results per page:

39 results

0 selected

39 results

0 selected